NBIX Snapshot | |
---|---|
Neurocrine Biosciences, Inc., a biopharmaceutical company, discovers, develops, and markets pharmaceutical products for the treatment of neurological, endocrine, and psychiatric diseases and disorders in the United States. The company is headquartered in San Diego, California. | |
VALUATION DATA | |
Market Capitalization | $13,715,119,000 | Price to Sales | 8.00 |
Earnings per Share | $2.4700 |
PE Ratio | 55.8 |
PRICE DATA | |
Most Recent Close | $137.9200 |
52 Week High | $7.27 |
52 Week Low | $6.14 |
50-Day Moving Average | $6.94 |
200-Day Moving Average | $36.6 |
All data are from Alpha Vantage as of today. For more infomation on NBIX see Stock Dividend, Valuation, Price and Financial Data for Investors |